STINGENI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 533
EU - Europa 381
AS - Asia 40
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 960
Nazione #
US - Stati Uniti d'America 531
IE - Irlanda 196
FI - Finlandia 41
UA - Ucraina 39
IT - Italia 35
SE - Svezia 31
CN - Cina 27
DE - Germania 12
AT - Austria 8
GB - Regno Unito 6
BE - Belgio 4
FR - Francia 4
IN - India 4
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CA - Canada 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
HK - Hong Kong 1
NL - Olanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 960
Città #
Chandler 205
Dublin 196
Jacksonville 56
Helsinki 41
New York 36
San Mateo 21
Princeton 20
Wilmington 20
Ann Arbor 11
Jinan 8
Vienna 8
Brussels 4
Beijing 3
Molise 3
Rome 3
San Francisco 3
Borås 2
Hangzhou 2
Hebei 2
Nanchang 2
Naples 2
Shanghai 2
Toronto 2
Bangalore 1
Boardman 1
Frankfurt am Main 1
Haikou 1
Harbin 1
Huizen 1
Kazan 1
Kursk 1
London 1
Monmouth Junction 1
Mumbai 1
Nanjing 1
Ningbo 1
Norwalk 1
Redwood City 1
Rockville 1
Sao Goncalo 1
Seattle 1
Shenyang 1
Siena 1
Singapore 1
Taizhou 1
Woodbridge 1
Zhengzhou 1
Totale 676
Nome #
Efficacia e tollerabilità di una crema liporestitutiva e lenitiva in pazienti con xerosi cutanea, dermatite atopica e eczema xerotico 86
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease 86
Dupilumab and COVID-19: what should we expect? 60
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study 57
The role of occupational dermatology in the COVID-19 outbreak 52
Drug-induced aseptic meningitis to ibuprofen: The first case confirmed by positive patch test 52
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 52
Four-week urticaria activity score-7 as a useful patient-reported outcome to assess chronic spontaneous urticaria: A multicentre study evaluation of adherence and patients’ perspective 51
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 50
Contact sensitivity to electrocardiogram electrodes due to acrylic acid: A rare cause of medical device allergy 47
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults 45
Contact allergy to 3-dimethylaminopropylamine in 5140 consecutive Italian patients: A one-year retrospective multicenter SIDAPA study 43
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 42
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients 40
Prevalence of Chronic Inducible Urticaria in Elderly Patients 40
Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology 39
Skin tests in the diagnosis of adverse drug reactions 39
Patch testing with textile dye mix in Italy: A 2-year multicenter SIDAPA study 38
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): a real-life retrospective cohort multicentre study on 438 subjects with chronic hand eczema 38
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 32
Totale 989
Categoria #
all - tutte 5.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202021 0 1 2 0 3 0 2 4 2 4 1 2
2020/2021141 12 14 0 35 14 3 17 1 20 1 24 0
2021/2022114 3 21 6 2 10 11 0 12 20 12 7 10
2022/2023591 61 47 9 73 24 52 0 33 251 25 8 8
2023/2024101 32 5 12 4 6 40 0 1 1 0 0 0
Totale 989